Tuberculosis Diagnostics Global Market Report 2022: High Prevalence in the Developing World Fuels Growth - ResearchAndMarkets.com

DUBLIN--(BUSINESS WIRE)--Dec 2, 2022--

The "Tuberculosis Diagnostics Market Size, Market Share, Application Analysis, Regional Outlook, Growth Trends, Key Players, Competitive Strategies and Forecasts, 2022 to 2030" report has been added to ResearchAndMarkets.com's offering.

This report on global tuberculosis diagnostics market studies various tuberculosis diagnostics test type. Healthcare regulatory agencies such as WHO, CDC are taking initiatives towards global awareness of tuberculosis and improvising the diagnostic methods. The large patient pool suffering with tuberculosis, rising public awareness regarding tuberculosis and early diagnosis and technological advancement in the testing methods such as Mantoux test, and Cytokine detection test are the driving factors for the tuberculosis diagnostics market.

The global tuberculosis diagnostics market is growing at a CAGR of 4.5% during the forecast period from 2022 to 2030. Tuberculosis accounts for a large share of the global infectious disease burden, resulting in about 9.6 million new cases and 1.5 million deaths per year.

Tuberculosis is highly prevalent in under developed parts of the world affecting millions of lives, especially in Asia and Africa. Currently, tuberculosis has also developed into more diverse and potent forms that are referred as multi-drug resistant (MDR) or extensively drug resistant (XDR) tuberculosis. These conditions are also spreading at a rapid rate and require extensive diagnostic and treatment measures to check its spread globally. According to World Health Organization (WHO) in 0.49 million new cases of MDR tuberculosis was recorded in 2016, and 47% of these cases were from China, India and Russia.

Continuous and effective control measures and programs carried out by WHO and other global health organizations such as Stop TB and DOTS (Directly Observed Treatment, Short-course) most developed nations have been able to minimize the spread of this disease. Various tuberculosis diagnostics tests are available in the global market for early and accurate diagnosis of the disease, thus ensuring proper treatment of the affected patient population. Some of the major commercially available tuberculosis diagnostic tests include nucleic acid tests, culture tests, tuberculin skin tests, chest X-ray, sputum smear microscopy, and drug susceptibility testing. The latest next-generation Xpert MTB/RIF Ultra diagnostic test by Cephied, Inc., has shown significant sensitivity in detection of Mycobacterium tuberculosis and is recommended by WHO.

Market Segmentation

Test

• Radiographic Methods
• Laboratory Methods
• Smear Microscopy
• Culture Based Test
• Nucleic Acid Testing
• Phage Assay
• Cytokine Detection Test
• Detection of Drug Resistance
• Mantoux Test

Key questions answered in this report

• What are the key micro and macro environmental factors that are impacting the growth of Tuberculosis Diagnostics market?
• What are the key investment pockets with respect to product segments and geographies currently and during the forecast period?
• Estimated forecast and market projections up to 2030.
• Which segment accounts for the fastest CAGR during the forecast period?
• Which market segment holds a larger market share and why?
• Are low and middle-income economies investing in the Tuberculosis Diagnostics market?
• Which is the largest regional market for Tuberculosis Diagnostics market?
• What are the market trends and dynamics in emerging markets such as Asia Pacific, Latin America, and Middle East & Africa?
• Which are the key trends driving Tuberculosis Diagnostics market growth?
• Who are the key competitors and what are their key strategies to enhance their market presence in the Tuberculosis Diagnostics market worldwide?

Key Topics Covered:

1. Preface

2. Executive Summary

3. Tuberculosis Diagnostics Market: Business Outlook & Market Dynamics

4. Tuberculosis Diagnostics Market: By Test, 2020-2030, USD (Million)

5. North America Tuberculosis Diagnostics Market, 2020-2030, USD (Million)

6. UK and European Union Tuberculosis Diagnostics Market, 2020-2030, USD (Million)

7. Asia Pacific Tuberculosis Diagnostics Market, 2020-2030, USD (Million)

8. Latin America Tuberculosis Diagnostics Market, 2020-2030, USD (Million)

9. Middle East and Africa Tuberculosis Diagnostics Market, 2020-2030, USD (Million)

10. Company Profile

Companies Mentioned

• Alere Inc.
• Abbott Laboratories
• Thermo Fisher Scientific Corporation
• Becton Dickinson and Company
• BioMerieux Company
• Cephied Inc.

For more information about this report visit https://www.researchandmarkets.com/r/csb47q

View source version on businesswire.com:https://www.businesswire.com/news/home/20221202005382/en/

CONTACT: ResearchAndMarkets.com

Laura Wood, Senior Press Manager

press@researchandmarkets.com

For E.S.T Office Hours Call 1-917-300-0470

For U.S./ CAN Toll Free Call 1-800-526-8630

For GMT Office Hours Call +353-1-416-8900

KEYWORD:

INDUSTRY KEYWORD: HEALTH OTHER HEALTH

SOURCE: Research and Markets

Copyright Business Wire 2022.